Alexander KarpAlexander Karp earned $1B in 2024

Most recently acquired 133,333 shares in Jul 2021. Currently holds stock worth $20.88M.

Compensation History

Annual executive compensation data for Christoph Westphal, M.D., Ph.D., including salary, bonuses, and stock awards.

Year

2013

Total Compensation

$0.00

Salary

$0.00

Bonus

$0.00

Other

$0.00

Salary

$0.00

Board Justification

The company aims to align executive compensation with performance and market standards, but no specific compensation was awarded to Dr. Westphal in 2013.

Bonus

$0.00

Board Justification

No bonus was awarded in 2013.

Other Compensation

$0.00

Board Justification

No other compensation was reported for 2013.

Restricted Stock

$0.000 N/A

Board Justification

No stock was vested in 2013 as no stock grants were made during the year.

Performance Metrics

No performance metrics were applicable as no compensation was awarded.

V

Christoph Westphal, M.D., Ph.D.

Founder and Ex-CEO of Verastem

Education

M.D., Ph.D.

Field of Expertise

Healthcare & Life Sciences - Medicine

Sector of Economy

Healthcare

Born

April 12, 1960 - 65 years ago

CEO of Verastem for

0 years 9 months (Sep 2012 - Jun 2013)

Previous Experience

President and Chief Executive Officer of the Company

Holdings

Track Christoph Westphal, M.D., Ph.D.'s stock holdings and portfolio value over time.

Insider Trading

Christoph Westphal, M.D., Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.

TCRX

$2.00M

TCRX at $15.00/share

Jul 20, 2021

Purchase

VSTM

$8.00M

VSTM at $6.50/share

Jan 28, 2015

Purchase

VSTM

11,622 shares

VSTM

Jan 8, 2015

Received

VSTM

$12.75K

VSTM at $8.50/share

Dec 19, 2014

Purchase

VSTM

$15.12K

VSTM at $7.56/share

May 14, 2014

Purchase

VSTM

25,826 shares

VSTM

Jan 7, 2014

Received

VSTM

$9.60K

VSTM at $9.60/share

Oct 31, 2013

Purchase

VSTM

$8.00K

VSTM at $10.00/share

Oct 31, 2013

Small Acquisition

VSTM

$9.06K

VSTM at $9.06/share

May 30, 2013

Purchase

VSTM

$7.53K

VSTM at $9.42/share

May 30, 2013

Small Acquisition

Rivals

Compare Christoph Westphal, M.D., Ph.D. with competitor CEOs and industry peers.